We recently received three of the best reviews from our patients:
“The best experience I could ask for, the whole staff was wonderful. I am so grateful! Dr. Martinez was the best doctor I’ve been too!”
“RSCNJ has the best staff when it comes to professionalism and knowledge. They always make you feel welcome and comfortable. Going to Dr. Mensah was the best decision my husband and I ever made!”
Our patients are the best, too. We thank all of them for choosing us for their fertility care. You can read more reviews of us on our web site.
In the largest genetic analysis of polycystic ovary syndrome (PCOS) performed to date, an international consortium, including researchers at the Icahn School of Medicine at Mount Sinai, conducted a whole genome association study to identify common genetic architecture for different diagnostic criteria used to define the syndrome. The results were published in the journal PLOS Genetics.
PCOS is among the most common endocrine disorders in reproductive-age women; it is a leading cause of infertility and type 2 diabetes. The origin of PCOS is unknown. It is currently diagnosed based on different sets of clinical criteria, which is controversial and possibly less accurate.
The researchers explored the genetic basis of PCOS by conducting a meta-analysis of seven studies involving more than 10,000 women with PCOS and 100,000 controls of European ancestry. These studies included 2,540 patients diagnosed using the National Institutes of Health criteria (high testosterone and irregular menstrual cycles); 2,669 patients using the Rotterdam criteria (high egg production); and 5,184 self-reported cases from the personal genetics company 23andMe.
With the benefit of this sample size, researchers were able to identify 14 gene variants that were associated with PCOS, including three that were identified for the first time. All the new genetic variants plausibly linked to both metabolic and reproductive features of PCOS.
“This study also indicates the enormous power of genome-wide association studies to provide insight into the disease. For the first time, we’re making real progress on understanding the causal pathways leading to PCOS and the diseases that are genetically related to it,” said Andrea Dunaif, MD, Chief of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes, and Bone Disease at the Icahn School of Medicine at Mount Sinai, and one of the senior authors of the study. Ultimately, Dr. Dunaif hopes that these biologic insights will enable the development of novel therapies for PCOS.
The longer a man is infertile, the lower his sperm count and other parameters of impaired sperm. That’s the conclusion in a BJU International study of 1,644 infertile men. Older age and higher body mass index were associated with a longer duration of infertility as well.
Approximately 15 percent of couples of reproductive age fail to achieve a wanted pregnancy within a 12-month period, despite regular unprotected sexual intercourse. Prolonged infertility has been considered a psychosocial stress for the infertile couple that may lead to poor marital adjustment and decreased quality of life, but the potential role of the duration of infertility in terms of couple’s reproductive health remains understudied.
“Our results suggest that duration of infertility should be considered a potential risk factor for impaired sperm parameters in infertile men. Also, infertile couples should be made aware of the associations found in this study,” said lead author Dr. Luca Boeri, of IRCCS San Raffaele Hospital and University Vita-Salute San Raffaele, in Italy.
When a woman cannot carry a healthy pregnancy, she can turn to a gestational carrier, a surrogate who carries the fetus created from the egg and sperm of the parents.
In our latest podcast, Dr. Alan Martinez explains how The Reproductive Science Center of NJ can help coordinate the care of the biological parents and gestational carrier for couples wishing to have children.
Listen to the podcast using the player below.
The Mediterranean diet is characterized by a high content of fruits, vegetables, olive oil, legumes and nuts. This healthy diet pattern has been associated with lower obesity and cardiometabolic risk in adults, but few studies have focused on children. A study published in the Journal of Pediatrics aimed at evaluating the association between adherence to a Mediterranean diet during pregnancy and growth patterns and cardiometabolic risk in early infancy.
The study was performed with data of over 2,700 pregnant women in Europe. The women filled in a questionnaire on dietary intake in the first and third trimester of pregnancy. In addition, the diet, weight and height of their offspring were followed-up from birth to age 4 years. Other tests such as blood analysis and blood pressure were also performed at age 4.
The results show that pregnant women with higher adherence to the Mediterranean diet had a 32% lower risk of having children with an accelerated growth pattern, as compared to offspring of women that did not follow such diet.
“These results support the hypothesis that a healthy diet during pregnancy can have a beneficial effect for child development,” the study authors claim.
A patient of ours had this to say about the care she received at RSCNJ:
“Dr. Mensah was wonderful. Very friendly and explained everything so we could understand. Everyone in the office made each visit easier and they are there for you for everything.”
Thanks to her, and to all our patients who posted reviews, which you can read on our web site.
We’d like to wish everyone a safe and Happy New Year.
Here’s hoping that all your fertility dreams come true in 2019.
A patient has nice things to say about her treatment at RSCNJ:
“This was such a positive experience for me and my husband. Dr. Martinez and his staff were amazing, especially Marianela at the front desk. Super responsive, caring and helpful!”
From your first visit to you last, we try to make every experience just like this one. Please see what other patients have to say about our care by visiting our web site.
There are 16 states in the U.S. that have laws requiring health insurance companies to provide coverage for infertility treatment, and New Jersey is one of them. The insurance mandate states that any insurance provider who provides pregnancy-related benefits must also cover infertility treatment and IVF costs. The law also requires health plans contracting to cover state employees and teachers to include the same infertility coverage.
What is covered? We have a comprehensive introduction to infertility treatment in New Jersey on our web site. If you have any questions, please give us a call.
All of us at Reproductive Science Center of New Jersey want to wish our patients, their families and friends—and especially all the small miracles we have helped welcome this year—a happy and safe holiday season.